Global Electrophoresis Reagents Market

1 INTRODUCTION OF GLOBAL ELECTROPHORESIS REAGENTSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL ELECTROPHORESIS REAGENTSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL ELECTROPHORESIS REAGENTS MARKET, BY APPLICATION
5.1 Protein Analysis
5.2 DNA & RNA Analysis

6 GLOBAL ELECTROPHORESIS REAGENTS MARKET, BY END USER
6.1 Academic & Research Institutions
6.2 Pharmaceutical & Biotechnology Companies
6.3 Hospitals & Diagnostic Laboratories
6.4 Other End Users

7 GLOBAL ELECTROPHORESIS REAGENTS MARKET, BY TECHNIQUE
7.1 Gel Electrophoresis
7.2 Capillary Electrophoresis

8 GLOBAL ELECTROPHORESIS REAGENTS MARKET, BY PRODUCT
8.1 Gels
8.1.1 Polyacrylamide Gels
8.1.2 Agarose Gels
8.1.3 Starch Gels
8.2 Dyes
8.2.1 Ethidium Bromide (ETBR) Dyes
8.2.2 Sybr Dyes
8.2.3 Other Dyes
8.3 Buffers
8.3.1 Tris-Acetate-Edta (TAE) Buffers
8.3.2 Other Buffers
8.4 Other Electrophoresis Reagents

9 GLOBAL ELECTROPHORESIS REAGENTSMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL ELECTROPHORESIS REAGENTSMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Thermo Fisher Scientific
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Sigma-Aldrich Corporation
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Bio-Rad Laboratories, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Qiagen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Merck Millipore
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 GE Healthcare
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Agilent Technologies, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Lonza Group, AG
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Takara Bio, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development

11.10 Harvard Bioscience, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development

11.11 Sebia Group
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development

12 Appendix
12.1 Related Reports